» Authors » Matthieu Foll

Matthieu Foll

Explore the profile of Matthieu Foll including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 4210
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Di Genova A, Mangiante L, Sexton-Oates A, Voegele C, Fernandez-Cuesta L, Alcala N, et al.
Gigascience . 2023 Jan; 12. PMID: 36705549
Background: Malignant pleural mesothelioma (MPM) is a rare understudied cancer associated with exposure to asbestos. So far, MPM patients have benefited marginally from the genomics medicine revolution due to the...
12.
Gabriel A, Atkins J, Penha R, Smith-Byrne K, Gaborieau V, Voegele C, et al.
J Natl Cancer Inst . 2022 May; 114(8):1159-1166. PMID: 35511172
Background: Germline genetic variation contributes to lung cancer (LC) susceptibility. Previous genome-wide association studies (GWAS) have implicated susceptibility loci involved in smoking behaviors and DNA repair genes, but further work...
13.
Mc Leer A, Foll M, Brevet M, Antoine M, Novello S, Mondet J, et al.
Lung Cancer . 2022 Feb; 167:98-106. PMID: 35183375
Introduction: Among the different mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors (TKIs) reported in EGFR-mutated lung adenocarcinoma (EGFR-LUAD) patients, histological transformation into small cell carcinoma (SCLC) occurs in...
14.
Moonen L, Mangiante L, Leunissen D, Lap L, Gabriel A, Hillen L, et al.
Int J Cancer . 2022 Jan; 150(12):1987-1997. PMID: 35076935
Limited number of tumor types have been examined for Orthopedia Homeobox (OTP) expression. In pulmonary carcinoids, loss of expression is a strong indicator of poor prognosis. Here, we investigated OTP...
15.
Nasrollahzadeh D, Roshandel G, Delhomme T, Avogbe P, Foll M, Saidi F, et al.
Int J Mol Sci . 2021 Jun; 22(11). PMID: 34073316
Circulating cell-free DNA (cfDNA) is emerging as a potential tumor biomarker. CfDNA-based biomarkers may be applicable in tumors without an available non-invasive screening method among at-risk populations. Esophageal squamous cell...
16.
Fernandez-Cuesta L, Mangiante L, Alcala N, Foll M
Virchows Arch . 2021 Jan; 478(1):73-80. PMID: 33411030
The diagnosis and classification of malignant pleural mesothelioma (MPM) is extremely challenging; obtaining an accurate histopathological diagnosis of the different types and subtypes requires expert assessment and suitable biopsies that...
17.
Hosen M, Forey N, Durand G, Voegele C, Bilici S, Avogbe P, et al.
Cancers (Basel) . 2020 Dec; 12(12). PMID: 33260905
Somatic mutations in the () promoter regions are frequent events in urothelial cancer (UC) and their detection in urine (supernatant cell-free DNA or DNA from exfoliated cells) could serve as...
18.
Gabriel A, Mathian E, Mangiante L, Voegele C, Cahais V, Ghantous A, et al.
Gigascience . 2020 Oct; 9(11). PMID: 33124659
Background: Lung neuroendocrine neoplasms (LNENs) are rare solid cancers, with most genomic studies including a limited number of samples. Recently, generating the first multi-omic dataset for atypical pulmonary carcinoids and...
19.
Galimberti M, Leuenberger C, Wolf B, Szilagyi S, Foll M, Wegmann D
Genetics . 2020 Oct; 216(4):1205-1215. PMID: 33067324
Allele frequencies vary across populations and loci, even in the presence of migration. While most differences may be due to genetic drift, divergent selection will further increase differentiation at some...
20.
Delhomme T, Avogbe P, Gabriel A, Alcala N, Leblay N, Voegele C, et al.
NAR Genom Bioinform . 2020 May; 2(2):lqaa021. PMID: 32363341
The emergence of next-generation sequencing (NGS) has revolutionized the way of reaching a genome sequence, with the promise of potentially providing a comprehensive characterization of DNA variations. Nevertheless, detecting somatic...